OMODEI, Umberto
 Distribuzione geografica
Continente #
NA - Nord America 4.440
AS - Asia 2.200
EU - Europa 1.423
SA - Sud America 428
AF - Africa 109
Continente sconosciuto - Info sul continente non disponibili 45
OC - Oceania 18
Totale 8.663
Nazione #
US - Stati Uniti d'America 4.389
SG - Singapore 763
CN - Cina 750
UA - Ucraina 541
BR - Brasile 377
HK - Hong Kong 279
DE - Germania 238
IN - India 143
FI - Finlandia 128
IT - Italia 100
FR - Francia 96
GB - Regno Unito 92
TR - Turchia 88
IE - Irlanda 74
RU - Federazione Russa 73
VN - Vietnam 68
NG - Nigeria 61
BD - Bangladesh 34
CA - Canada 24
EE - Estonia 24
AR - Argentina 22
ZA - Sudafrica 19
AU - Australia 17
MX - Messico 15
IQ - Iraq 14
SE - Svezia 12
ES - Italia 11
ID - Indonesia 9
JP - Giappone 9
SA - Arabia Saudita 8
CO - Colombia 7
NL - Olanda 7
EC - Ecuador 6
PL - Polonia 6
TN - Tunisia 6
BE - Belgio 5
CL - Cile 5
DZ - Algeria 5
EU - Europa 5
LT - Lituania 5
MA - Marocco 5
JO - Giordania 4
KE - Kenya 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
HN - Honduras 3
IL - Israele 3
PY - Paraguay 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
AT - Austria 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
KR - Corea 2
KZ - Kazakistan 2
MY - Malesia 2
PT - Portogallo 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GR - Grecia 1
GY - Guiana 1
HT - Haiti 1
JM - Giamaica 1
LK - Sri Lanka 1
LY - Libia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TO - Tonga 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.624
Città #
Fairfield 473
Woodbridge 464
Ashburn 388
Jacksonville 362
Houston 355
Singapore 355
Ann Arbor 286
Hong Kong 278
Cambridge 215
Seattle 203
Wilmington 191
San Jose 171
Beijing 163
Princeton 146
The Dalles 131
Nanjing 111
Dublin 74
Chandler 71
Columbus 71
Los Angeles 71
Istanbul 66
Abuja 61
Lauterbourg 60
Dearborn 53
Helsinki 53
Council Bluffs 50
New York 41
São Paulo 33
Nanchang 31
Buffalo 30
Changsha 28
San Diego 27
Milan 26
Ho Chi Minh City 25
Tallinn 24
Redondo Beach 23
Kunming 21
Jiaxing 20
Jinan 20
Hebei 19
Moscow 19
Tianjin 19
Santa Clara 18
Brescia 17
London 17
Boardman 16
Munich 16
San Francisco 16
Shenyang 16
Washington 16
Chennai 14
Dallas 14
Hanoi 14
Rio de Janeiro 14
Shanghai 14
Chicago 12
Hangzhou 12
Johannesburg 12
Orem 11
Kocaeli 10
Atlanta 9
Belo Horizonte 9
Brooklyn 9
Manchester 9
Ningbo 9
Tokyo 9
Verona 9
Guangzhou 8
Hefei 8
Sydney 8
Campinas 7
Indiana 7
Lanzhou 7
Mexico City 7
Norwalk 7
Nuremberg 7
Caxias do Sul 6
Porto Alegre 6
Zhengzhou 6
Boston 5
Brussels 5
Criciúma 5
Curitiba 5
Denver 5
Des Moines 5
Dhaka 5
Melbourne 5
Mumbai 5
Ribeirão Preto 5
Salvador 5
Sorocaba 5
Stockholm 5
Taiyuan 5
Warsaw 5
Alexandria 4
Amman 4
Charlotte 4
Frankfurt am Main 4
Fuzhou 4
Montreal 4
Totale 5.833
Nome #
Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women 186
Can salin infusion sonohysterography (SIS) replace diagnostic hysteroscopy in the uterine cavity evaluation of infertile women? 174
Effect of acupuncture on rates of pregnancy among women undergoing in vitro fertilization 169
A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: The HOT study 167
Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries 160
Clinical Impact of a New Italian Law Regulation on Assisted Reproduction Technologies 160
Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users. 158
Chromosome Abnormalities and Yq microdeletions in Infertile italian couples referred for assisted reproductive tecnique 158
A New HRT Regimen Using Estradiol Valerate and Cyproterone Acetate: Clinical Data 152
Determinants of body mass index in women around menopause attending menopause clinics in Italy. 152
FSH receptor polymorphisms in a population of infertile women and controls 151
Determinants of age at menopause in women attending menopause clinics in Italy. 148
Identification of osteoporosis risk in postmenopausal women by the combined use of ultrasounds and clinical factors 146
Risk factors for clinically diagnosed uterine fibroids in women around menopause. 145
Effect of soy-derived isoflavones on hot flashes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries 144
General and medical factors associated with hormone replacement therapy among women attending menopause clinics in Italy 143
A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers. 139
Factors associated with total cholesterol levels in women around menopause attending menopause clinics in Italy 139
A New HRT Regimen Using Estradiol Valerate and Cyproterone Acetate: Impact on Lipid Metabolism 137
Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional study. 136
The Effect of HRT on Endometrial Thickness (ET) and Uterine Arterial Blood Flow Assessed by Transvaginal Ultrasound (TVU). 136
Risk identification of osteoporosis in postmenopausal women by a simple algorithm based on ultrasound densitometry and body mass index 136
Endometrial thickness and histological abnormalities in women on hormonal replacement therapy: a transvaginal ultrasound/hysteroscopic study 135
Serum progesterone level on the day of oocyte retrieval correlates with the ovarian response but not predict pregnancy rate 133
Risk factors for high blood pressure in women attending menopause clinics in Italy. 132
Risk of low bone density in women attending menopause clinics in Italy 132
Endometrial evaluation with transvaginal ultrasound during hormone therapy: a prospective multicenter study. 131
Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003. 131
Frequency of Cardiovascular Risks Factor in Women Attending Menopause Clinics: Findings from the ICARUS Data Base 131
CUMCS: FINDINGS FROM THE ICARUS DATA BASE 129
A new method for free testosterone assay: clinical evaluation. 129
Anti-Mullerian hormone (AMH): Prognostic value in assisted reproductive technology (ART) 128
How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. 127
Osteoporosis Risk Profile for Peri-and Postmenopausal Women Attending Menopause Clinics in Italy 127
Risk of low bone density in women attending menopause clinics in Italy. 124
Endometrial Changes and Doppler Flow Evaluation in Postmenopausal Breast Cancer Patients on Tamoxifen (TAM): A Transvaginal Ultrasound (TVU)/Hysterescopy Study 123
Ovulation induction with intravenous gonadotropin-releasing hormone 122
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. 120
Risk factors for genital prolapse in non-hysterectomized women around menopause. Results from a large cross-sectional study in menopausal clinics in Italy 118
The impact of HRT on endometrial thickness—do cut‐off values exist? 114
A new method for free testosterone assay: clinical evaluation. 112
Doppler flow evaluation of endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen 112
Sequential Conjugated Estrogens Plus Medrogestone HRT Regimen Versus Tibolone: A Comparative Randomized Study 111
Continuous combined HRT in post-menopause: two regimen comparative study 110
Premature ovarian failure: frequency and risk factors among women attending a network of menopause clinics in Italy. 110
EVALUATION OF BLEEDING AND CONTROL OF CLIMACTERIC SYMPTOMS OBSERVED WITH TWO TRANSDERMAL PREPARATIONS CONTAINING ESTRADIOL AND NORETHISTERONE ACETATE 108
Profiles and endocrine correlations in endometrial carcinoma. 106
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 105
The effect of HRT on uterine arterial blood flow in postmenopausal women assessed by transvaginal color doppler sonography (TVDS) 97
Doppler flow evaluation of endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen 97
Pituitary microprolactinoma, bromocriptine, and pregnancy: follow-up of 74 cases 96
Endometrial ultrasound transvaginal (TVU) assessment in postmenopausal women on hormone replacement therapy (HRT) 95
Identificazione del rischio di osteoporosi in donne in postmenopausa mediante l’uso combinato di ultrasuoni e fattori clinici. 95
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial 95
Effects of Recombinant Follicle-Stimulating Hormone on Bone Turnover Markers in Infertile Women Undergoing in Vitro Fertilization Procedure 94
La patologia endometriale e la sorveglianza della paziente in postmenopausa 94
Profiles and endocrine correlations in endometrial carcinoma. 91
The effect of HRT on uterine arterial blood flow in postmenopausal women assessed by transvaginal color doppler sonography (TVDS) 91
Endometrial Evaluation in Postmenopausal Bleeding: Transvaginal Sonografy Versus Hysteroscopy 91
Endometrial ultrasound transvaginal (TVU) assessment in postmenopausal women on hormone replacement therapy (HRT) 87
Rischio oncologico 87
Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen: a transvaginal ultrasound study 85
Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen: a transvaginal ultrasound study 85
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 83
EFFECTS OF SOY-DERIVED ISOFLAVONES ON HOT FLUSHES AND VASCULAR REACTIVITY 82
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 82
Polycystic ovary syndrome: long-term evolution. 80
Outlook on Continuous Estrogen-Progestin Therapy. 79
Premarin 0.625 vs Estraderm TTS 50 Have These Two" Standard Doses" the Same Biological Effects? 79
Ovarian hyperstimulation syndrome (OHS): a case of severe OHS. 79
Polycystic ovary syndrome: long-term evolution. 77
Mammella: è possibile la chemioprevenzione? 77
Fibrocystic Disease of the Breast Associated with Pituitary‐Ovarian Dysfunction: Results of Treatment with Bromocriptine 69
Totale 8.663
Categoria #
all - tutte 40.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.285


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022446 0 119 3 28 1 40 27 39 35 52 8 94
2022/2023296 75 1 6 27 20 100 0 19 26 3 6 13
2023/2024378 10 2 35 43 22 46 18 12 103 20 2 65
2024/20251.247 4 1 7 187 134 81 142 19 174 71 300 127
2025/20262.123 217 298 142 278 302 136 320 61 153 137 52 27
2026/2027157 97 60 0 0 0 0 0 0 0 0 0 0
Totale 8.663